BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18923435)

  • 1. Hypertension and peripheral arterial disease.
    Bennett PC; Silverman S; Gill P
    J Hum Hypertens; 2009 Mar; 23(3):213-5. PubMed ID: 18923435
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral arterial disease and isolated systolic hypertension: the ATTEST study.
    Safar ME; Priollet P; Luizy F; Mourad JJ; Cacoub P; Levesque H; Benelbaz J; Michon P; Herrmann MA; Blacher J
    J Hum Hypertens; 2009 Mar; 23(3):182-7. PubMed ID: 18830251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.
    Mechtouff L; Touzé E; Steg PG; Ohman EM; Goto S; Hirsch AT; Röther J; Aichner FT; Weimar C; Bhatt DL; Alberts MJ; Mas JL;
    J Intern Med; 2010 Jun; 267(6):621-33. PubMed ID: 20210837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study.
    Kownator S; Cambou JP; Cacoub P; Léger P; Luizy F; Herrmann MA; Priollet P
    Arch Cardiovasc Dis; 2009; 102(8-9):625-31. PubMed ID: 19786266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral vascular disease and hypertension: a forgotten association?
    Makin A; Lip GY; Silverman S; Beevers DG
    J Hum Hypertens; 2001 Jul; 15(7):447-54. PubMed ID: 11464253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
    Mostaza JM; Lahoz C; Martín-Jadraque R; Sanmartín MA; Vicente I; Tranche S; Taboada M; Mantilla T; Monteiro B; Sanchez-Zamorano MA;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):34-8. PubMed ID: 19237995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial stiffness: a tool to tailor antihypertensive therapy.
    Narain VS; Puri A
    Indian Heart J; 2008; 60(6):578-83. PubMed ID: 19276500
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension.
    Campbell-Scherer DL; Green LA
    Prim Care; 2005 Dec; 32(4):1011-25, viii. PubMed ID: 16326225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microparticles and arterial disease.
    Blann A; Shantsila E; Shantsila A
    Semin Thromb Hemost; 2009 Jul; 35(5):488-96. PubMed ID: 19739039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensives.
    Daniels V; Casey A
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):319-35, viii. PubMed ID: 10370934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on pharmacological therapy.
    Notaro LA; Usman MH; Burke JF; Siddiqui A; Superdock KR; Ezekowitz MD
    Cardiovasc Ther; 2009; 27(3):199-215. PubMed ID: 19689620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure and vascular cognitive impairment: the debate continues.
    Birns J; Kalra L
    J Hum Hypertens; 2006 Jan; 20(1):1-3. PubMed ID: 16195707
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?
    Messerli FH; Panjrath GS
    J Am Coll Cardiol; 2009 Nov; 54(20):1827-34. PubMed ID: 19892233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension: how low should the pressure be?].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 1988 May; 132(21):948-50. PubMed ID: 3374690
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of complicated arterial hypertension].
    Arabidze GG; Bogoslovskiĭ VA
    Ter Arkh; 1982; 54(11):138-48. PubMed ID: 7157166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombophilias and peripheral arterial occlusive disease].
    Le Hello C; Blacher J; Conard J; Piette JC; Constans J
    J Mal Vasc; 2008 Sep; 33(3):126-36. PubMed ID: 18554834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and risk of coronary, cerebral, and peripheral vascular disease in a large Dutch population with familial hypercholesterolemia.
    Rana JS; Jansen AC; Zwinderman AH; Nieuwdorp M; van Aalst-Cohen ES; Jukema JW; Trip MD; Kastelein JJ
    Diabetes Care; 2006 May; 29(5):1125-7. PubMed ID: 16644652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and treatment of hypertension and coronary heart disease].
    Mendoza-González C; Rosas M; Estrada CL; Lorenzo JA; Méndez A; Martínez-Reding J; Martínez-Sánchez C; Pastelín G; Férez-Santander SM; Attie F
    Arch Cardiol Mex; 2008; 78 Suppl 2():S2-58-73. PubMed ID: 18938686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.